Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?

Sylvia Hartl, Jose Luis Lopez-Campos
European Respiratory Journal 2016 48: 281-282; DOI: 10.1183/13993003.00885-2016
Sylvia Hartl
1Ludwig Boltzmann Institute of COPD and Respiratory Epidemiology, Vienna, Austria
2Dept. of Resp. and Crit. Care, Otto Wagner Hospital, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hartl.sylvia@aon.at
Jose Luis Lopez-Campos
3Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Hospital Universitario Virgen del Rocío, Seville, Spain
4CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

It is high time for a holistic approach to COPD exacerbation including each suitable intervention to the risk profile http://ow.ly/iUok300hb8V

From the authors:

We thank Ernesto Crisafulli, Mónica Guerrero, Alfredo Chetta and Antoni Torres for their differentiated perspective on the topic of hospital readmission of chronic obstructive pulmonary disease (COPD).

We agree that hospital readmission is a complex surrogate parameter whereby the short period after dismission is related to a fragile health condition of the patient. The close correlation of readmission to increased mortality is another indicator of this vulnerable condition of the COPD patient, following acute exacerbation.

The pilot project of the European audit analysed only readmissions of the COPD patients due to respiratory reasons, in order to assess the risk related to the original hospital admitted exacerbation. This was also very well described in the data by Hurst et al. [1], who demonstrated that the first exacerbation is followed by a second in nearly one-third of patients within 8 weeks. Moreover, we found a correlation of the readmission rate and the severity of respiratory failure during the first admission and in line with other publications, a consecutive increase in mortality after readmission [2–4]. Guerrero et al. [5] reported a correlation with hypercapnia but not with the rate of ventilatory support, not even with admission to intensive care units. This is opposite to our study, which relates the risk of readmission to the severity of the exacerbation (respiratory acidosis, need of ventilation) and not only to disease severity. The need for ventilatory support is an expression of reduced ventilatory capacity in the acute situation and we know that muscle fatigue and overload in accordance with systemic corticosteroids have a potential for critical illness myopathy or neuropathy [6, 7]. Therefore, in the short course after exacerbation ventilatory support was identified as an indicator of an instable condition and a risk factor for readmission.

Due to the observational character of the European COPD Audit study we are not able to predict the potential for the prevention of readmission or death by a single measure of care. However we observed a huge variation of care within each participating country and between countries according to the treatment of acute respiratory failure and the referral to rehabilitation after discharge. The analysis of the level of adherence to management recommendations of acute exacerbation of COPD showed a disappointing result of only 15% of accordance with suggested standard procedures [8]. These findings mirror the ignorance towards the challenge of acute exacerbation of COPD on admission as well as a passive attitude towards ongoing COPD management after discharge. The complexity of COPD exacerbation and of COPD patients overall should not result in reduced treatment approaches.

Therefore, we think that it is high time to accept hospital admitted acute COPD-exacerbation as a risk profile that needs a strict acute care programme and a secured follow-up management starting with post-acute rehabilitation including noninvasive ventilation and long-term oxygen therapy for according patients.

Complexity management is requested as a holistic approach in knowledge-management driven programmes, according to the combination of each single evidence-based intervention that may be suitable to the patients’ risk profile as suggested by Kirschner et al. [9].

The assessment of quality of care is a powerful tool to monitor the changes in management and promote the discussion of care models. McCarthy et al. [10] showed a successful implementation of an improved COPD management at the emergency department after identification of weaknesses. The pilot of The European Audit intends to be a start for such activities.

Footnotes

  • Conflict of Interest: Disclosures can be found alongside the online version of this article at erj.ersjournals.com

  • Received May 3, 2016.
  • Accepted May 4, 2016.
  • Copyright ©ERS 2016

References

  1. ↵
    1. Hurst JR,
    2. Donaldson GC,
    3. Quint JK, et al.
    Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 179: 369–374.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Roberts CM,
    2. Stone RA,
    3. Buckingham RJ, et al.
    Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations. Thorax 2011; 66: 43–48.
    OpenUrlAbstract/FREE Full Text
    1. Groenewegen KH,
    2. Schols AM,
    3. Wouters EF
    . Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124: 459–467.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Elliott MW
    . Noninvasive ventilation in chronic ventilatory failure due to chronic obstructive pulmonary disease. Eur Respir J 2002; 20: 511–514.
    OpenUrlFREE Full Text
  4. ↵
    1. Guerrero M,
    2. Crisafulli E,
    3. Liapikou A, et al.
    Readmission for acute exacerbation within 30 days of discharge is associated with a subsequent progressive increase in mortality risk in COPD patients: a long-term observational study. PLoS One 2016; 11: e0150737.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Brochard L,
    2. Isabey D,
    3. Piquet J, et al.
    Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask. N Engl J Med 1990; 323: 1523–1530.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Needham DM
    . Mobilizing patients in the intensive care unit: improving neuromuscular weakness and physical function. JAMA 2008; 300: 1685–1690.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Roberts CM,
    2. Lopez-Campos JL,
    3. Pozo-Rodriguez F, et al.
    European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions. Thorax 2013; 68: 1169–1171.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Kirschner M,
    2. Bauch A,
    3. Agusti A, et al.
    Implementing systems medicine within healthcare. Genome Med 2015; 7: 102.
    OpenUrlCrossRefPubMed
  9. ↵
    1. McCarthy C,
    2. Brennan JR,
    3. Brown L, et al.
    Use of a care bundle in the emergency department for acute exacerbations of chronic obstructive pulmonary disease: a feasibility study. Int J Chron Obstruct Pulmon Dis 2013; 8: 605–611.
    OpenUrlPubMed
PreviousNext
Back to top
View this article with LENS
Vol 48 Issue 1 Table of Contents
European Respiratory Journal: 48 (1)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?
Sylvia Hartl, Jose Luis Lopez-Campos
European Respiratory Journal Jul 2016, 48 (1) 281-282; DOI: 10.1183/13993003.00885-2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?
Sylvia Hartl, Jose Luis Lopez-Campos
European Respiratory Journal Jul 2016, 48 (1) 281-282; DOI: 10.1183/13993003.00885-2016
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Asthma and allergy
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Agora

Correspondence

  • Clinical outcomes of bronchiectasis in India
  • Reply: Clinical outcomes of bronchiectasis in India
  • Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
Show more Correspondence

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society